Functional expression of the CXCR4 chemokine receptor is induced by RET/PTC oncogenes and is a common event in human papillary thyroid carcinomas-Reference-Cited by-同舟云学术

Functional expression of the CXCR4 chemokine receptor is induced by RET/PTC oncogenes and is a common event in human papillary thyroid carcinomas

Published:2004-06-07 Issue:35 Volume:23 Page:5958-5967
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Castellone Maria D,Guarino Valentina,De Falco Valentina,Carlomagno Francesca,Basolo Fulvio,Faviana Pinuccia,Kruhoffer Mogens,Orntoft Torben,Russell John P,Rothstein Jay L,Fusco Alfredo,Santoro Massimo,Melillo Rosa Marina

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/1207790.pdf

Reference58 articles.

1. Asai N, Murakami H, Iwashita T and Takahashi M . (1996). J. Biol. Chem., 271, 17644–17649.

2. Aust G, Steinert M, Kiessling S, Kamprad M and Simchen C . (2001). J. Clin. Endocrinol. Metab., 86, 3368–3376.

3. Bachelder RE, Wendt MA and Mercurio AM . (2002). Cancer Res., 62, 7203–7206.

4. Balkwill F and Mantovani A . (2001). Lancet, 357, 539–545.

5. Barbero S, Bonavia R, Bajetto A, Porcile C, Pirani P, Ravetti JL, Zona GL, Spaziante R, Florio T and Schettini G . (2003). Cancer. Res., 63, 1969–1974.

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Causal relationship between inflammatory cytokines and autoimmune thyroid disease: a bidirectional two-sample Mendelian randomization analysis;Frontiers in Immunology;2024-03-20

2. Saga of monokines in shaping tumour-immune microenvironment: Origin to execution;Cytokine;2022-09

3. Comparative evaluation of somatostatin and CXCR4 receptor expression in different types of thyroid carcinoma using well-characterised monoclonal antibodies;BMC Cancer;2022-07-07

4. Resistance to RET targeted therapy in Thyroid Cancer: Molecular basis and overcoming strategies;Cancer Treatment Reviews;2022-04

5. Coexisting CLT in PTC is an independent predictor of tumor aggressiveness for patients aged under 55: a retrospective analysis of 635 patients;BMC Endocrine Disorders;2022-03-07